196 related articles for article (PubMed ID: 15164965)
1. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
Bergeret M; Boutros N; Raymond J
Int J Antimicrob Agents; 2004 Mar; 23(3):247-53. PubMed ID: 15164965
[TBL] [Abstract][Full Text] [Related]
2. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
Pinheiro L; Brito CI; Pereira VC; Oliveira A; Bartolomeu AR; Camargo CH; Cunha ML
Microb Drug Resist; 2016 Jun; 22(4):283-93. PubMed ID: 26623676
[TBL] [Abstract][Full Text] [Related]
4. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance of community and hospital acquired Staphylococcus aureus isolates to oxacillin and glycopeptides.
Anwar MS; Bokhari SR
J Coll Physicians Surg Pak; 2003 Jan; 13(1):33-6. PubMed ID: 12685973
[TBL] [Abstract][Full Text] [Related]
7. Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Rodríguez-Vidigal FF; Vera Tomé A; Robles Marcos M
Rev Esp Quimioter; 2011 Jun; 24(2):74-8. PubMed ID: 21666998
[TBL] [Abstract][Full Text] [Related]
8. In-vitro bactericidal activity of cefpirome and cefamandole in combination with glycopeptides against methicillin-resistant Staphylococcus aureus.
Bergeret M; Raymond J
J Antimicrob Chemother; 1999 Feb; 43(2):291-4. PubMed ID: 11252338
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of the bactericidal activity of cefepime and cefpirome in association with glycopeptides against Staphylococci sensitive and resistant to methicillin].
Husson MO; Fruchart A; Izard D
Pathol Biol (Paris); 1998 Apr; 46(4):279-83. PubMed ID: 9769909
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus.
Chaudhury A; Kumar AG
Indian J Med Microbiol; 2007 Jan; 25(1):50-2. PubMed ID: 17377353
[TBL] [Abstract][Full Text] [Related]
11. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Shibl AM; Ishag AH; Durgham SM
APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of ceftaroline against staphylococci from prosthetic joint infection.
Park KH; Greenwood-Quaintance KE; Patel R
Diagn Microbiol Infect Dis; 2016 Feb; 84(2):141-3. PubMed ID: 26602948
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program.
Marshall SA; Wilke WW; Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 1998 Mar; 30(3):205-14. PubMed ID: 9572028
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
Nunes AP; Teixeira LM; Iorio NL; Bastos CC; de Sousa Fonseca L; Souto-Padrón T; dos Santos KR
Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome.
Pasticci MB; Moretti A; Stagni G; Ravasio V; Soavi L; Raglio A; Vailati F; Cardaccia A; Santucci A; Papili R; Sgrelli A; Pallotto C; Baldelli F
Ann Clin Microbiol Antimicrob; 2011 Jun; 10():26. PubMed ID: 21658248
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant staphylococcal bacteremia in patients with hematologic malignancies: clinical and microbiological retrospective comparative analysis of S. haemolyticus, S. epidermidis and S. aureus.
Falcone M; Micozzi A; Pompeo ME; Baiocchi P; Fabi F; Penni A; Martino P; Venditti M
J Chemother; 2004 Dec; 16(6):540-8. PubMed ID: 15700845
[TBL] [Abstract][Full Text] [Related]
17. In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci.
Raymond J; Vedel G; Bergeret M
J Antimicrob Chemother; 1996 Dec; 38(6):1067-71. PubMed ID: 9023655
[TBL] [Abstract][Full Text] [Related]
18. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Klastersky J; Van der Auwera P
J Antimicrob Chemother; 1986 Mar; 17 Suppl A():19-24. PubMed ID: 2940212
[TBL] [Abstract][Full Text] [Related]
19. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]